Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Open Access
- 1 December 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 10 (6) , 707-722
Abstract
(2010). Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 10, No. 6, pp. 707-722. doi: 10.1586/erp.10.72Keywords
This publication has 55 references indexed in Scilit:
- Public drug expenditure in the Republic of IrelandExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- Forecasting drug utilization and expenditure in a metropolitan health regionBMC Health Services Research, 2010
- Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of ItalyHealth Policy, 2010
- Ongoing pharmaceutical reforms in FranceApplied Health Economics and Health Policy, 2010
- Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future directionExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Insight into recent reforms and initiatives in Austria: implications for key stakeholdersExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Recent National and Regional Drug Reforms in SwedenPharmacoEconomics, 2008
- Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countriesHealth Policy, 2007
- Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in FinlandHealth Policy, 2007